Novo Nordisk shares plunge after forecasting steep drop in sales #health

"When you get a pricing headwind, you feel the pressure more."

Novo Nordisk CEO Mike Doustdar tells Francine Lacqua he is "very confident" that volumes will compensate for price decreases